Home / Drug shortages / Sodium Bicarbonate Injection

Sodium Bicarbonate Injection — FDA Drug Shortage

Current — Amphastar Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on 03/01/2017. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Amphastar Pharmaceuticals, Inc.
Package NDC
76329-3352-1
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)
Initial Posting
03/01/2017
Revised Date

Reason

Demand increase for the drug

FDA data resources